- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Peking University Health Science Center Hospital
Totalt 6004 resultater
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringHER2 positive eller mistenkelige positive svulsterKina
-
Peking University Cancer Hospital & InstituteRekrutteringGastrisk adenokarsinomKina
-
Peking University Cancer Hospital & InstituteFullførtTykktarmskreft | Kirurgi | Levermetastaser | Minimal restsykdom | Sirkulerende tumor-DNAKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteFullført
-
Peking University Cancer Hospital & InstituteUkjentAvansert ikke-plateepitel, ikke-småcellet lungekreftKina
-
Peking University Cancer Hospital & InstituteUkjentBukspyttkjertelkreft | Gastrisk adenokarsinom | Kolangiokarsinom | HER2-negativ brystkreftKina
-
Peking University Cancer Hospital & InstituteAktiv, ikke rekrutterende
-
Peking University Cancer Hospital & InstituteFullført
-
Peking University Cancer Hospital & InstituteUkjentQOL; Livskvalitet; Magekreft; Gastrectomy; Neoadjuvant kjemoterapiKina
-
Peking University Cancer Hospital & InstituteUkjentLymfom | Positron-utslippstomografi | Svulst, solidKina
-
Peking University Cancer Hospital & InstituteUkjent
-
Peking University Cancer Hospital & InstituteUkjentAvansert slimhinnemelanomKina
-
Peking University Cancer Hospital & InstituteUkjentKarsinom, ikke-småcellet lunge | Docetaxel | NivolumabKina
-
Peking University Cancer Hospital & InstituteUkjentTilbakevendende småcellet lungekreftKina
-
Peking University Cancer Hospital & InstituteUkjent
-
Peking University Cancer Hospital & InstituteUkjentAvansert melanomKina
-
Peking University Cancer Hospital & InstituteUkjentHepatocellulært karsinomKina
-
Peking University Cancer Hospital & InstituteUkjentMetastatisk nyrecellekarsinomKina
-
Peking University Cancer Hospital & InstituteFullførtBrystneoplasmer | Neoplasma MetastaseKina
-
Peking University Cancer Hospital & InstituteUkjentMelanom | Neoplasma Metastase | TOR serin-treoninkinaserKina
-
Peking Union Medical College HospitalPeking University Cancer Hospital & InstituteRekrutteringDifferensiert kreft i skjoldbruskkjertelenKina
-
Peking UniversityPeking University Cancer Hospital & Institute; Peking University International... og andre samarbeidspartnereRekrutteringNK/T celle lymfom nrKina
-
Peking University Cancer Hospital & InstituteRekrutteringB7H3 | CD276 Affibody | PET/CT-avbildningKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåNeoplasma i magen | Lymfeknutemetastase | RADIONUKLID BILDER
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåMelanom | Metastatisk melanom | Slimhinne melanomKina
-
Peking University Cancer Hospital & InstituteRekrutteringKreft i fordøyelsessystemetKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåMetastatisk kastrasjonsresistent prostatakreft
-
Peking University Cancer Hospital & InstituteRekrutteringSCLC, omfattende trinnKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-opererbart hepatocellulært karsinom | Oligometastatisk sykdomKina
-
Peking University Cancer Hospital & InstituteRekrutteringTykktarmskreft | LungekreftKina
-
Peking University Cancer Hospital & InstituteRekrutteringIkke-småcellet lungekreft | Konsolidering immunterapi | Strålebehandling eller sekvensiell kjemoradiasjonKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåCovid-19 | Kirurgi-komplikasjonerKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennåMykvevssarkom
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Temozolomid | Apatinib | Camrelizumab | Akralt melanom | Neoadjuvans | Patologisk responsKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering
-
Peking University Cancer Hospital & InstituteRekrutteringMelanom | Lungekreft | PD-L1 | PET/CTKina
-
Peking University Cancer Hospital & InstituteHar ikke rekruttert ennå
-
Peking University Cancer Hospital & InstituteRekruttering